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INTRODUCTION
Health risks associated with obesity are 
well established; the 2007 Foresight report 
estimates that, by 2050, obesity-related 
illness could cost the UK NHS over £9 billion 
per year.1 In May 2014, the National Institute 
for Health and Care Excellence (NICE) 
published guidelines recommending that 
primary care practitioners use behavioural 
weight management programmes as a 
first-line intervention for adults who are 
overweight or obese.2
Although many patients who are 
overweight would welcome more assistance 
with weight management from their GP, by 
positioning causality and treatment of obesity 
as an issue of lifestyle choices and individual 
responsibility, both health professionals 
and patients generally perceive weight 
management as falling outside the GP’s 
remit.3–6 Qualitative research also suggests 
that, by delivering the interventions in 
the community, commercial weight 
management programmes align better with 
participants’ explanatory model of obesity 
and expectations regarding appropriate 
treatment.4 This is supported by evidence 
suggesting GP-led interventions have 
limited effectiveness in helping people lose 
weight, and that commercial programmes 
are more clinically and cost effective.7–10 
In the UK, Public Health and NHS 
commissioners are currently able to 
purchase 12-week referral packages 
from a number of commercial weight-
loss providers at a reduced cost. GPs and 
other health professionals are thereby 
able to provide their patients with vouchers 
to attend meetings and use internet-
based resources. However, there is some 
scepticism among patients about the profit-
making interests of commercial companies 
and concern over the public funding of 
weight-loss services.5 
This study draws on interviews with 
participants from a randomised controlled 
trial (RCT) of primary care referral to a 
commercial weight-loss programme. It 
examines their attitudes and beliefs about 
accessing a commercial weight-loss 
programme via their doctor, and the ways 
in which these relate to their weight-loss 
experience. This study explores their views 
about an NHS commercial partnership and 
the provision of 'free' weight management, 
paid for by the NHS, in order to understand 
the contextual factors that may facilitate 
participation in the programme. 
METHOD
Design and setting
This qualitative study was embedded 
within the WRAP Weight Loss Referrals for 
Adults in Primary Care) (ISRCTN82857232) 
randomised controlled trial, the full protocol 
for which is published elsewhere.11 The 
trial recruited adults who were overweight 
or obese and randomised them to either: 
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Abstract
Background
Referral to a commercial weight-loss 
programme is a cost-effective intervention 
that is already used within the NHS. Qualitative 
research suggests this community-based, non-
medical intervention accords with participants’ 
view of weight management as a lifestyle issue. 
Aim
To examine the ways in which participants’ 
attitudes and beliefs about accessing a 
commercial weight management programme 
via their doctor relate to their weight-loss 
experience, and to understand how these 
contextual factors influence motivation and 
adherence to the intervention.
Design and setting
A qualitative study embedded in a randomised 
controlled trial evaluating primary care referral to 
a commercial weight-loss programme in adults 
who are overweight or obese in England. The 
study took place from June–September 2013. 
Method
Twenty-nine participants (body mass index 
[BMI] ≥28 kg/m2; age ≥18 years), who took 
part in the WRAP (Weight Loss Referrals for 
Adults in Primary Care) trial, were recruited 
at their 3-month assessment appointment 
to participate in a semi-structured interview 
about their experience of the intervention and 
weight management more generally. Interviews 
were audiorecorded, transcribed verbatim, and 
analysed inductively using a narrative approach.
Results
Although participants view the lifestyle-based, 
non-medical commercial programme as an 
appropriate intervention for weight management, 
the referral from the GP and subsequent clinical 
assessments frame their experience of the 
intervention as medically pertinent with clear 
health benefits. 
Conclusion
Referral by the GP and follow-up assessment 
appointments were integral to participant 
experiences of the intervention, and could be 
adapted for use in general practice potentially to 
augment treatment effects.
Keywords
general practice; obesity; primary health care; 
qualitative research; referral and consultation; 
weight loss.
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referral to a commercial programme 
(Weight Watchers®) for 12 weeks; referral 
to the same programme for 52 weeks; 
or a brief self-help intervention. Clinical 
measures (weight, waist circumference, 
body composition, and blood pressure) and 
self-report questionnaires were completed 
at baseline, 3, 12, and 24 months.
Recruitment and sampling
For the main trial, participating GP practices 
used their lists to identify all eligible males 
and females, (aged ≥18 years with a body 
mass index [BMI] >28 kg/m2) and sent 
them invitations to participate. In total, 
1269 participants were recruited by three 
research centres (MRC Human Nutrition 
Research, Cambridge; the University of 
Oxford; and the University of Liverpool) from 
23 GP practices across the UK.
A purposeful sample of 29 participants 
from the Cambridge centre participated in 
this qualitative study. A maximum-variation 
(heterogeneity) sampling technique was 
used to select potential interviewees 
based on BMI, intervention arm, and 
demographic information (age, sex, 
ethnicity, and education) obtained during 
the telephone screening questionnaire and 
through a questionnaire at the baseline 
visit. At the 3-month visit, one author met 
with selected participants (including some 
who had stopped attending meetings 
but not withdrawn from follow-up) and 
invited them to participate in the qualitative 
study. Interested participants were given a 
participant information sheet to take home 
with them and were asked to contact the 
author if they were happy to take part in an 
interview. 
Participants could choose whether to be 
interviewed in their home or in a private 
office at the University of Cambridge. 
Interviews were not held where study 
procedures were conducted. This was to 
reduce associations between the interview 
and the measurement visits of the trial to 
encourage participants to speak openly 
about their experiences of the intervention 
to which they had been assigned. The 
interviewer told participants that she 
worked alongside the trial but was not part 
of the core trial team. 
Data collection and analysis
Face-to-face semi-structured home 
interviews with participants were 
conducted by one author between June and 
September 2013. The interview focused on 
patients’ experiences, attitudes, and beliefs 
concerning:
• the GP referral process to the commercial 
programme;
• their participation in the commercial 
programme; and
• the idea of being overweight as a 'medical' 
issue. 
Interviews were audiorecorded, 
transcribed verbatim, and analysed 
inductively using a narrative approach.12 In 
this way, although the interviews followed 
a common topic guide, the structure 
generated first-order descriptive codes 
that were augmented through a process 
of inductive analytic coding to identify the 
major underlying themes.13 
Data were coded by one author using 
NVivo (version 10); the first five interviews 
were coded blind by all authors to ensure 
consistency and appropriateness of 
categories. All authors are experienced 
qualitative researchers, but from different 
disciplinary backgrounds. Regular 
discussion and reflection thereby ensured 
that codes and coding were achieved 
through consensus.
RESULTS
Participant characteristics are described 
in Table 1. Five main topics emerged from 
analysis of the data that address the core 
research question.
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How this fits in
Randomised controlled trials have shown 
that referral to a commercial weight-loss 
programme is a cost-effective intervention 
for people who are overweight and obese, 
and qualitative research has shown that 
it accords with patients' views of weight 
management as a non-medical lifestyle 
issue. This study suggests that patients 
do not see a clear demarcation between 
the primary care and commercial 
sectors, and that the referral from the 
GP and subsequent clinical assessments 
(undertaken as part of a randomised 
controlled trial) frame patient experience 
of this community-based intervention to 
strengthen the focus on health benefits. 
The perceived investment and medical 
observation from the GP may increase 
motivation of patients to attend the 
commercial programme and engage in 
weight management. Short follow-up 
appointments, with clinical measurements 
fed back to the GP, could be incorporated 
into clinical practice to potentially enhance 
attendance, adherence, and sustain 
intervention effects for patients referred to 
commercial programmes. 
Accounts of usual primary care
Patients for whom weight loss had been 
raised as a topic during a GP consultation 
reported that they received little to no 
practical support, for example stating:
'You’re kind of left to your own devices to 
deal with it.' (Female, 61)
’I had a problem with my back and the 
most useful thing [the doctor], could come 
up with was some pain medicine and say 
"You’re too big, think about losing some 
weight", which is fair as a comment but 
then nothing came to say, you know, "This 
is who you could talk to to get some help 
and some information" … anything practical 
was lacking … If I go to the doctor because 
I’ve broke my arm they’re not going to tell 
me "You broke your arm, go get it bandaged 
up", they’re going to do something about 
it or at least tell me what to do about it 
… I found that a bit annoying at the time.’ 
(Female, 32)
Many said that although they had been 
given leaflets these were inadequate and 
contained outdated or incorrect information, 
further cementing their perception that the 
GP was not invested in providing weight- 
loss support:
’I think first of all she gave me a leaflet 
which I took home and I showed it to my 
son and my son said “What the hell? Ah!” 
And he pointed out all the wrong things, 
like it said you could eat dried fruit and he 
said “Dried fruit is full of sugar!” [patient 
has type 2 diabetes]. He was pointing out all 
the discrepancies and I pointed it out to [the 
doctor] and she said “Hmm, the leaflets are 
a bit old” [laughs].’ (Female, 53)
Despite these general feelings, patients 
did not regard the GP as the appropriate 
person to help them. Although patients 
expressed some concern about the health 
consequences of excess weight, they did 
not view being overweight or obese as 
primarily medical issues, and therefore 
felt this should not become a burden on 
their GP or the NHS. They consequently 
welcomed what they saw as referral to 
more appropriate support beyond the health 
service. 
The GP letter
Patients were recruited to the trial by their 
GP, who sent a signed letter to eligible 
patients in the practice. In this letter, patients 
were asked to contact the research team if 
they wished to participate. All subsequent 
contact regarding the trial, including all 
measurement visits, was made by the 
research team. Nevertheless, patients 
welcomed what they interpreted to be a 
personal invitation from their doctor, and 
they frequently mentioned this letter rather 
than any of the following communications. 
Although the support was overtly through 
an existing commercial programme, the 
sense of personalised support from the GP 
was enduring. Patients viewed the letter 
as evidence that they had been specially 
'nominated' (female, 61) or 'selected' 
(female, 48) by their GP, who 'doesn’t offer it 
[the programme] to everyone' (female, 36). 
This motivated patients not only to sign up to 
the programme but also to attend meetings:
‘I thought my doctor’s helping me, she’s not 
just sitting back and going “Just get on with 
it”, you know, … if you just done it on your 
own you’ve got no support or anything really, 
you’re just plodding on every week … I’ve 
got nobody to say that to. But this is why it’s 
really pushing me to do this and I can go into 
my doctor’s office and she’ll go “God haven’t 
you lost weight [name of participant]”. You 
e250  British Journal of General Practice, April 2015
Table 1. Participant characteristics recorded at the baseline 
appointment. BMI was measured by research staff and all other 
characteristics are self-reported
    Brief 
 CP12 CP52 intervention Total
Sex 
  Male 5 4 0 9 
  Female 7 8 5 20
Age, years 
  <40 4 5 0 9 
  40–49 2 3 2 7 
  50–59 3 1 1 5 
  ≥60 3 3 2 8
BMI, kg/m2 
  <30 2 1 0 3 
  30–34.9 6 6 2 14 
  35–39.9 3 2 2 7 
  ≥40 1 3 1 5
Ethnicity     
  Asian/Asian British 1 1 0 2 
  Black/black British 0 0 0 0 
  Mixed/multiple ethnic groups 1 2 0 3 
  White British 9 7 5 20 
  White other 1 2 0 3
Education     
  Higher degree 3 4 0 7 
  University degree 5 0 2 7 
  A Level or equivalent 2 3 1 6 
  GCSE or equivalent 2 1 0 3 
  Other (vocational) 0 2 2 4 
  Not stated 0 2 0 2
BMI = body mass index. CP12 = 12-week commercial programme. CP52 = 52-week commercial programme.
know, because I’m really friendly with my 
doctor, obviously because I go there every 
blinking month. So I want to do it as well 
so she can say to me, “God you are really 
getting your act together now”, you know, 
I’m getting rid of this weight.’ (Female, 70)
In addition, receiving such communication 
from their doctor framed their weight as a 
serious issue:
‘It’s not like I didn’t know or don’t know that 
I’m much too big but it’s not something that 
people normally bring up. It just seemed like 
well if my doctor starts sending me letters 
… now might be a good time.’ (Female, 32)
Overall, patients equated the letter from 
their GP with a more typical NHS referral 
letter from primary to secondary care, and 
recognised it as being the key means to 
access specialist resources and services. 
As a result, the letter played an important 
symbolic role for participants. 
The significance of receiving vouchers
Patients viewed the vouchers, which 
are used to pay for weekly meetings, 
as a further symbolic link between the 
commercial programme, their GP, and the 
NHS. Although the vouchers were given 
to patients by the research team, patients 
interpreted them as originating from what 
they understood to be their GP’s referral. 
With this came a sense of moral and 
financial obligation to the GP to attend the 
commercial programme meetings:
‘It would be rather embarrassing to be 
perfectly honest to go to a weight-loss thing 
and say “Yeah [bangs table for emphasis] 
thank you for the free Weight Watchers 
things but I just didn’t bother!” … I don’t want 
to let the doctors down.’ (Male, 38)
 Because participants felt that their weight 
was caused by 'Self-indulgence' (Female, 
62), and was '... essentially [their] fault.' 
(Female, 34), they frequently expressed 
guilt about drawing on NHS resources to 
address their problem:
‘GPs have got sick people to see rather than 
people who just eat too much.’ (Female, 46)
In this context, participants welcomed the 
use of vouchers to access a commercial 
programme because they would not be 
'Wasting [the GP’s] time' (Female, 53), and 
because they believed it would cost less 
than the medical interventions that they 
associated with their problem (for example, 
bariatric surgery). Vouchers were therefore 
seen as a means to ensure funding was not 
taken from the 'deserving' sick, whom were 
regarded as suffering from 'real' diseases: 
‘Because the NHS is strapped for cash, 
there’s people that have got far more 
serious issues than the fact that I like 
eating chocolate and crisps, like you’ve 
got people dying of cancer that they can’t 
even save, there isn’t enough money 
available … I would consider that far more 
serious, because … a lot of cancers are not 
preventable … so my weight, my weight gain 
is preventable if I could sort myself out and 
do it, so I wouldn’t expect someone else to 
pay for me to get a grip basically [laughs].’ 
(Female, 34)
It is worth noting that although, in many 
accounts, use of the vouchers enabled 
participants to talk of attending the weight-
loss programme ‘for free’, the majority 
acknowledged that the service was being 
paid for, and they therefore felt a sense of 
debt:
‘I know I’m going to Weight Watchers each 
week, and I’m not going to let myself down 
and I’m not letting everybody else down, you 
know ‘cos it’s costing money, not for me 
personally but for everybody else, you might 
as well save the taxpayer, you know, and it’s 
as simple as that.’ (Female, 70)
Feeling obliged to use the vouchers 
because they were free (to them) was 
contrasted with the idea that if they had paid 
for the service themselves this would have 
given them the right not to attend:
‘I thought I can’t mess people around, 
if I had decided to do [the programme] 
myself it was very possible that I would 
have done exactly what other people did 
[when] joining gyms, which is to pay and not 
go, and I think well it’s alright … [laughs] 
at least if I pay I don’t have to go ... I would 
have felt I’d done enough in paying and it 
would have confirmed all my worst feelings 
about myself, but because I felt that I would 
be wasting a valuable resource I’ve felt 
entirely motivated to do those first visits.’ 
(Female, 59)
These findings reveal how the vouchers 
were perceived to be more than a substitute 
means for payment, and symbolically 
functioned to blur the demarcation between 
the NHS — considered a free health 
service but with limited resources — and a 
commercial programme.
British Journal of General Practice, April 2015  e251
The value of clinical measurements
Although participants attending the 
commercial programme were weighed 
by the group leader when they attended 
meetings, they attributed very different 
meanings to measurements conducted by 
the research team at both the baseline and 
3-month assessment appointments. These 
measurements were not only regarded 
as more accurate, but were invariably 
contextualised by what the participants felt 
was a clinical framing.
Although all participants acknowledged 
that they were overweight, the vast majority 
with a BMI >30 kg/m2 did not recognise 
themselves as being obese. In contrast 
to themselves, participants described 
obese individuals in extreme terms such 
as 'elephantine', (Male, 63), 'housebound 
and [needing] someone else to wash them', 
(Male, 63), unable 'to get out of bed ... or go 
to the toilet', (Female, 34), 'like [you see on] 
these American [television] programmes', 
(Female, 59).
Unlike the term 'overweight', patients 
associated 'obesity' with what they 
considered were far more serious health 
consequences. Therefore they expressed 
surprise when they were told that their 
weight would classify them as obese. 
As a result, some reported feeling more 
motivated to lose weight because their 
problem was suddenly one associated with 
ill health:
‘So when I went to the first meeting of the 
experiment they showed me the chart and 
said “You’re here and this is for obese” 
[laughs] … before I thought I would be in 
the overweight category … I definitely do not 
want to be in the obese category … I guess 
you are in an unhealthy place … whereas 
if I was only in the overweight category 
… it would lack the fact that I’m — I was 
surprised … that I’m not somewhere where I 
want to be, … I’m so out of control that I don’t 
even know that I’m in a bad place … so that 
was for me more motivational … because 
I’m so far on the chart, so far beyond what I 
thought I was, so not in control.’ (Male, 28)
Waist circumference, body fat percentage, 
and in some cases blood pressure and 
BMI were experienced as relatively novel 
and additional forms of measurement 
that provided a further 'shock' factor not 
experienced when simply measuring body 
weight:
' [The weight charts] are the same that I’ve 
seen many times over really, there was no 
surprise to me … ‘cos you know I’m a serial 
weight loser and putter oner [laughs] so I’ve 
seen it all … The only thing I was interested 
in finding out was the percentage of my body 
fat because I’ve never had any means of 
doing that … that was a bit shocking ‘cos I’ve 
got a lot of body fat.’ (Female, 34)
Tied to an explanation of reducing one’s 
risk factors for disease, and extending to 
other ideas they held about the body and 
health, these measurements gave meaning 
to weight loss. Patients reported that 
their previous attempts to lose weight by 
attending a commercial weight-loss service 
had been driven more by appearance, and 
usually precipitated a special occasion or a 
holiday, and that they felt more committed 
to losing weight for measurable health 
improvements:
 
‘When I got to the last few weeks before 
I knew I was coming back to be weighed, 
the only thing I really could focus on or 
think about was that I wanted to know 
my circumference around my waist … [the 
researcher] said “You’ve lost 15 centimetres 
which means you’re out of the danger zone, 
you’ve reduced to negligible your chance of 
getting diabetes”, that one fact was much 
more easy for me to digest … and hold on 
to. I have lost weight and now I can see for 
myself all of the benefits … So that really 
helps to sort of tie it down to something 
that’s very, very tangible.’ (Female, 48)
The measurement visits conducted by the 
research team provided participants with 
a new visual language concerning weight 
loss. For example, they spoke about wanting 
to move out of the 'danger zone' or 'dark red 
part of the graph.' (Female, 48). 
‘Putting it on more of a chart, my blood 
pressure and that, … it’s helped me 
[because] I saw the health benefits of it … 
it reminds me what I’m doing [and] how it’s 
improved.' (Female, 37)
By seeing their position on charts, 
participants felt that what it means to be 
'healthier' was made more concrete and 
they expressed a sense of accomplishment 
from seeing their position alter.
Attending the commercial programme as 
a ‘patient’ and trial participant
Some participants reported that they had 
not attended a commercial programme 
before because they thought that the 'target 
audience' were people who wished to lose 
weight to improve their 'appearance'. 
(Male, 38).
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Participants considered usual attendance 
at the commercial programme as more of a 
leisure activity, which, in a context of limited 
financial resources, was often viewed as a 
luxury rather than a necessity:
‘I’d always put my family first and think, you 
know, we need that [money] somewhere 
else … I’d feel guilty that again my family 
is suffering because of my weight, and 
then they’d go without again because of my 
problem.’ (Female, 37)
Men also communicated gendered 
perceptions of the commercial programme 
as a 'knitting club' or 'Women’s Institute 
type of situation.' (Male, 51). However, 
within the trial, the GP invitation to the 
commercial programme not only served 
to redefine weight loss as being a medical 
goal for those who previously thought their 
problems were primarily aesthetic, but also 
endorsed the programme as suitable for 
those who already wanted to lose weight for 
health reasons. 
Patients were also motivated by the fact 
that they were attending meetings with 
people who, unlike them, were paying to 
attend:
‘I need to embrace this opportunity, 
12 weeks free, because it is expensive to 
go, you know, £5 a week … my friend joined 
about a week before I did it.' (Female, 37)
‘I feel a bit guilty to them ‘cos … they’re 
paying to come here.’ (Female, 34)
The vouchers, provided in an initial 
12-week pack to those randomised to both 
commercial programme interventions, 
served to make explicit the time 
commitment required. This was contrasted 
with the open nature of commitment for 
non-referral attendees, who, instead of 
time, are encouraged to pursue a weight-
loss goal. 
Although those in the intervention 
arms valued the weekly weigh-in at the 
commercial programme meetings and 
reported that this influenced their daily 
food choices, the measurement visits at the 
research centre provided further motivation. 
Participants described this as a 'compound 
effect' : 
' [The measurement visit] doesn’t contribute 
towards the weight loss but it did contribute 
towards attending Weight Watchers. So 
if you think about it, you’ve got the day-
to-day stuff where “Do I, am I going to 
eat a cupcake?” “No, because I’ve got 
Weight Watchers coming up”. There’s 
that motivation but there’s also “Should I 
actually bother going to Weight Watchers? 
Well it takes about half an hour or more out 
of my time … but I’ve got the study coming 
up so I really should turn up. So you’ve got 
the two different motivators … So I think 
there is a compound effect there.’ (Male, 38)
Participants also thought the 12- and 
24-month measurement appointments 
would keep them on track once their 12/52-
week programme had finished. In this sense, 
the follow-up measurements maintained a 
sense of commitment to weight loss and so, 
from their perspective, constituted part of 
the intervention.
Overall, features of trial participation 
meant that participants reported that 
attending the commercial programme 
during the trial was different from if they 
had been more usual attendees. Although 
this might only be conjecture on their part, it 
seems clear that apparently inconsequential 
features of the study, introduced to enable 
the trial to take place, nevertheless played 
an important symbolic role. In particular, the 
letter and vouchers served to authenticate 
the status of the participant as an NHS 
‘patient’ and, where relevant, shifted their 
views of weight to being primarily a health 
issue.
DISCUSSION
Summary
Primary care referral to a commercial 
programme aligns with patients’ 
understanding of being overweight or obese 
as states that may have negative health 
consequences, but are ostensibly lifestyle 
issues requiring a non-medical solution. 
Despite this, participants in this trial 
appeared to carry their interactions with their 
GP and the NHS (and research staff viewed 
as conduits of the former) through to their 
experiences of the commercial programme 
via such symbolic elements as the GP letter 
and vouchers, shaping their experiences 
outside the NHS environment. The letter 
from the GP endorsed participation in the 
commercial programme and engendered 
a sense of obligation, providing motivation 
to attend. The weekly vouchers were 
experienced as a symbolic resource that 
maintained a link with the GP, legitimised 
meeting attendance as a 'medical' necessity 
rather than a luxury, and associated the 
programme with public funding and a 
sense of responsibility. Finally, the range 
of clinical measurements, in combination 
with a discussion about disease risk, 
provided participants with a new language 
through which they could acknowledge 
the seriousness of being overweight or 
obese and recognise the 'tangible' health 
benefits of weight loss. While participants 
acknowledged the impact that body weight 
had on their health, they did not view the 
NHS as the most appropriate space to 
address their weight. The clinical framing 
nevertheless provided a validating impetus 
for participants to seek support in an overtly 
non-clinical domain that aligned with their 
perception of weight loss as a non-medical 
‘lifestyle’ issue. 
Strengths and limitations
A qualitative design with open-ended 
questions allowed participants to focus on 
aspects of their experience that were most 
important to them. Home interviews with a 
researcher not directly involved in the trial 
may have facilitated free expression. For 
pragmatic reasons, the current study only 
included participants from the Cambridge 
centre of the trial. However, within this 
centre, participants were purposely selected 
to maximise demographic diversity. 
Although participants were informed that 
the trial and assessments were for research 
purposes and separate from both their 
GP and the commercial intervention, they 
did not always perceive these distinctions. 
This can be considered a limitation in 
the attempt to isolate the impact of the 
intervention. However, this 'limitation' is 
likely present but not acknowledged in 
most similar studies, and it is important 
to identify influential contextual factors 
outside the intervention itself. For this 
reason, the current study evaluated the 
ways in which the intervention and the trial 
procedures impacted patient experience in 
order to suggest how both aspects can be 
leveraged by GPs in practice.
Comparison with existing literature
Previous studies have shown that people 
often distance themselves from the social 
stereotype of 'obesity' and therefore do not 
acknowledge the degree to which they are 
overweight or the health risks associated 
with this.14,15 This study supports previous 
findings that adults who are overweight or 
obese feel ambivalent about approaching 
GPs for help with weight loss and see 
community-based support groups as a 
more appropriate intervention. 3,5,6 
However, in contrast to comparative 
studies that reinforce the distinction between 
commercial and health service sectors,5,16 
this study provides a more nuanced 
interpretation of primary care referral 
to commercial programmes, and shows 
how patients experience the partnership 
between the two sectors. The findings that 
the GP introduction by referral letter and 
the taking of clinical measurements at 
follow-up appointments may enhance the 
intervention experience echoes previous 
research that suggests 'free' GP referral for 
services which normally cost people money 
often encourage participation.5,17 
The current study also suggests that 
by being able to visualise their charted 
measurements with regard to disease risk 
helps people acknowledge their current 
weight status and the associated health 
consequences, providing a new language 
with which they can experience a sense of 
progress that verbal expressions of weight 
alone cannot provide. 
Implications for research and practice
This study found that the letter of invitation, 
sent to all eligible participants in the 
practice, but individually addressed and 
signed by their GP, was interpreted as 
a personalised medical recommendation. 
The use of trial support staff to take a 
small number of clinical measurements 
and give easy-to-understand visual 
feedback framed the intervention around 
clear health goals. Patients perceived these 
measurements as medical monitoring 
because they were copied to their GP. If 
the main WRAP trial confirms previous 
findings that commercial programmes are 
more effective than usual primary care 
services,8,10 then it may be valuable to 
consider to what extent explicit GP and 
NHS linkage to commercial programmes 
may provide an additional 'active ingredient' 
in treating obesity. Short follow-up 
appointments (similar to those provided by 
the trial), with clinical measurements fed 
back to the GP, could be implemented to 
potentially enhance attendance, adherence, 
and sustain intervention effects. Further 
research should explore the most effective 
way for practitioners to conduct referrals 
and monitor progress in order to maximise 
the benefits for patients participating in 
commercial programmes.
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